AKT1 and plasma cell myeloma: Since PTEN is one of the potential targets along the PI3K/Akt pathway, the modulation of its expression is a potential strategy for treatment of MM [18-20], and further studies are needed to investigate the PTEN inactivation process in multiple myeloma.